INFI Annual Net Income
-$44.37 M
+$893.00 K+1.97%
31 December 2022
Summary:
As of January 21, 2025, INFI annual net profit is -$44.37 million, with the most recent change of +$893.00 thousand (+1.97%) on December 31, 2022. During the last 3 years, it has risen by +$2.69 million (+5.71%).INFI Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
INFI Quarterly Net Income
-$9.96 M
+$1.09 M+9.86%
30 June 2023
Summary:
As of January 21, 2025, INFI quarterly net profit is -$9.96 million, with the most recent change of +$1.09 million (+9.86%) on June 30, 2023. Over the past year, it has increased by +$2.03 million (+16.94%).INFI Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
INFI TTM Net Income
-$40.95 M
+$2.03 M+4.72%
30 June 2023
Summary:
As of January 21, 2025, INFI TTM net profit is -$40.95 million, with the most recent change of +$2.03 million (+4.72%) on June 30, 2023. Over the past year, it has increased by +$5.84 million (+12.48%).INFI TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
INFI Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +2.0% | +16.9% | +12.5% |
| 3 y3 years | +5.7% | -5.1% | +5.1% |
| 5 y5 years | -6.1% | -43.0% | +13.0% |
INFI Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | -287.6% | -109.6% | -273.1% |
Infinity Pharmaceuticals Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2023 | - | -$9.96 M(-9.9%) | -$40.95 M(-4.7%) |
| Mar 2023 | - | -$11.04 M(+19.7%) | -$42.98 M(-3.1%) |
| Dec 2022 | -$44.37 M(-2.0%) | -$9.23 M(-13.9%) | -$44.37 M(-5.2%) |
| Sept 2022 | - | -$10.72 M(-10.6%) | -$46.79 M(+0.0%) |
| June 2022 | - | -$11.99 M(-3.6%) | -$46.79 M(+1.6%) |
| Mar 2022 | - | -$12.44 M(+6.7%) | -$46.07 M(+1.8%) |
| Dec 2021 | -$45.26 M(+11.8%) | -$11.65 M(+8.8%) | -$45.26 M(+2.4%) |
| Sept 2021 | - | -$10.71 M(-4.9%) | -$44.21 M(+2.7%) |
| June 2021 | - | -$11.27 M(-3.1%) | -$43.03 M(+4.4%) |
| Mar 2021 | - | -$11.63 M(+9.7%) | -$41.23 M(+1.8%) |
| Dec 2020 | -$40.49 M(-14.0%) | -$10.60 M(+11.2%) | -$40.49 M(-1.9%) |
| Sept 2020 | - | -$9.53 M(+0.6%) | -$41.27 M(-4.4%) |
| June 2020 | - | -$9.47 M(-13.0%) | -$43.16 M(-2.4%) |
| Mar 2020 | - | -$10.89 M(-4.4%) | -$44.20 M(-6.1%) |
| Dec 2019 | -$47.06 M(+318.2%) | -$11.38 M(-0.3%) | -$47.06 M(+7.2%) |
| Sept 2019 | - | -$11.42 M(+8.6%) | -$43.90 M(+129.9%) |
| June 2019 | - | -$10.51 M(-23.5%) | -$19.10 M(+22.8%) |
| Mar 2019 | - | -$13.74 M(+67.2%) | -$15.55 M(+38.1%) |
| Dec 2018 | -$11.25 M(-73.1%) | -$8.22 M(-161.4%) | -$11.25 M(+8.9%) |
| Sept 2018 | - | $13.38 M(-292.2%) | -$10.33 M(-66.5%) |
| June 2018 | - | -$6.96 M(-26.3%) | -$30.81 M(-24.5%) |
| Mar 2018 | - | -$9.45 M(+29.5%) | -$40.80 M(-2.4%) |
| Dec 2017 | -$41.83 M(+39.0%) | -$7.30 M(+2.7%) | -$41.83 M(-27.2%) |
| Sept 2017 | - | -$7.10 M(-58.1%) | -$57.46 M(-17.7%) |
| June 2017 | - | -$16.95 M(+61.9%) | -$69.86 M(<-9900.0%) |
| Mar 2017 | - | -$10.47 M(-54.3%) | $88.00 K(-100.3%) |
| Dec 2016 | -$30.10 M(-76.6%) | -$22.93 M(+17.6%) | -$30.10 M(-35.1%) |
| Sept 2016 | - | -$19.50 M(-136.8%) | -$46.36 M(-395.7%) |
| June 2016 | - | $52.99 M(-230.3%) | $15.68 M(-120.7%) |
| Mar 2016 | - | -$40.66 M(+3.8%) | -$75.74 M(-41.0%) |
| Dec 2015 | -$128.38 M(+637.1%) | -$39.19 M(-192.1%) | -$128.38 M(-0.9%) |
| Sept 2015 | - | $42.54 M(-210.7%) | -$129.53 M(+88.1%) |
| June 2015 | - | -$38.43 M(-58.8%) | -$68.86 M(+0.6%) |
| Mar 2015 | - | -$93.30 M(+131.3%) | -$68.45 M(+293.1%) |
| Dec 2014 | -$17.42 M(-86.3%) | -$40.34 M(-139.1%) | -$17.41 M(+74.2%) |
| Sept 2014 | - | $103.22 M(-371.5%) | -$10.00 M(-93.2%) |
| June 2014 | - | -$38.02 M(-10.0%) | -$147.15 M(+3.8%) |
| Mar 2014 | - | -$42.27 M(+28.4%) | -$141.72 M(+11.8%) |
| Dec 2013 | -$126.78 M(+134.9%) | -$32.92 M(-3.0%) | -$126.78 M(-10.0%) |
| Sept 2013 | - | -$33.94 M(+4.1%) | -$140.84 M(+59.1%) |
| June 2013 | - | -$32.59 M(+19.3%) | -$88.50 M(+25.4%) |
| Mar 2013 | - | -$27.33 M(-41.8%) | -$70.57 M(+30.8%) |
| Dec 2012 | -$53.96 M(+34.8%) | -$46.98 M(-355.3%) | -$53.97 M(+156.5%) |
| Sept 2012 | - | $18.40 M(-225.5%) | -$21.04 M(-59.1%) |
| June 2012 | - | -$14.66 M(+36.7%) | -$51.39 M(+6.0%) |
| Mar 2012 | - | -$10.72 M(-23.7%) | -$48.46 M(+21.0%) |
| Dec 2011 | -$40.04 M | -$14.06 M(+17.7%) | -$40.04 M(+0.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2011 | - | -$11.95 M(+1.8%) | -$40.02 M(-18.4%) |
| June 2011 | - | -$11.73 M(+408.7%) | -$49.02 M(+13.4%) |
| Mar 2011 | - | -$2.31 M(-83.6%) | -$43.24 M(-11.7%) |
| Dec 2010 | -$48.98 M(+56.6%) | -$14.04 M(-33.0%) | -$48.98 M(+17.7%) |
| Sept 2010 | - | -$20.95 M(+252.6%) | -$41.62 M(+38.7%) |
| June 2010 | - | -$5.94 M(-26.2%) | -$30.00 M(-15.2%) |
| Mar 2010 | - | -$8.05 M(+20.6%) | -$35.38 M(+13.1%) |
| Dec 2009 | -$31.28 M(-232.2%) | -$6.68 M(-28.4%) | -$31.28 M(-241.1%) |
| Sept 2009 | - | -$9.33 M(-17.7%) | $22.17 M(+16.0%) |
| June 2009 | - | -$11.32 M(+186.7%) | $19.10 M(-0.9%) |
| Mar 2009 | - | -$3.95 M(-108.4%) | $19.28 M(-18.5%) |
| Dec 2008 | $23.65 M(-240.0%) | $46.77 M(-477.5%) | $23.65 M(-176.4%) |
| Sept 2008 | - | -$12.39 M(+11.1%) | -$30.97 M(+50.5%) |
| June 2008 | - | -$11.15 M(-2738.7%) | -$20.57 M(+51.4%) |
| Mar 2008 | - | $422.50 K(-105.4%) | -$13.59 M(-19.6%) |
| Dec 2007 | -$16.90 M(-40.6%) | -$7.85 M(+292.8%) | -$16.90 M(+16.8%) |
| Sept 2007 | - | -$2.00 M(-52.0%) | -$14.47 M(-16.0%) |
| June 2007 | - | -$4.16 M(+44.0%) | -$17.22 M(-15.8%) |
| Mar 2007 | - | -$2.89 M(-46.7%) | -$20.46 M(-28.1%) |
| Dec 2006 | -$28.45 M(-21.8%) | -$5.42 M(+14.2%) | -$28.45 M(-13.4%) |
| Sept 2006 | - | -$4.75 M(-35.8%) | -$32.85 M(-12.7%) |
| June 2006 | - | -$7.40 M(-32.0%) | -$37.65 M(+19.1%) |
| Mar 2006 | - | -$10.88 M(+10.7%) | -$31.62 M(+25.0%) |
| Dec 2005 | -$36.37 M(+6.7%) | -$9.82 M(+2.9%) | -$25.29 M(-51.5%) |
| Sept 2005 | - | -$9.55 M(+597.7%) | -$52.09 M(+24.6%) |
| June 2005 | - | -$1.37 M(-69.9%) | -$41.79 M(+5.3%) |
| Mar 2005 | - | -$4.55 M(-87.6%) | -$39.68 M(+16.4%) |
| Dec 2004 | -$34.09 M(-3319.2%) | -$36.62 M(-4982.5%) | -$34.09 M(-945.2%) |
| Sept 2004 | - | $750.10 K(+1.3%) | $4.03 M(+5.4%) |
| June 2004 | - | $740.30 K(-29.2%) | $3.83 M(+109.6%) |
| Mar 2004 | - | $1.05 M(-30.2%) | $1.83 M(+72.5%) |
| Dec 2003 | $1.06 M(-101.7%) | $1.50 M(+174.8%) | $1.06 M(-102.1%) |
| Sept 2003 | - | $545.00 K(-143.2%) | -$51.32 M(-2.6%) |
| June 2003 | - | -$1.26 M(-554.5%) | -$52.67 M(-13.8%) |
| Mar 2003 | - | $277.50 K(-100.5%) | -$61.07 M(-1.7%) |
| Dec 2002 | -$62.11 M(+457.2%) | -$50.88 M(+6189.7%) | -$62.11 M(+382.5%) |
| Sept 2002 | - | -$808.90 K(-91.6%) | -$12.87 M(-30.4%) |
| June 2002 | - | -$9.66 M(+1164.8%) | -$18.49 M(+90.4%) |
| Mar 2002 | - | -$764.00 K(-53.3%) | -$9.71 M(-12.9%) |
| Dec 2001 | -$11.15 M(-4.7%) | -$1.64 M(-74.5%) | -$11.15 M(+15.7%) |
| Sept 2001 | - | -$6.42 M(+623.5%) | -$9.63 M(+150.8%) |
| June 2001 | - | -$887.70 K(-59.7%) | -$3.84 M(-68.7%) |
| Mar 2001 | - | -$2.20 M(+1723.7%) | -$12.27 M(+4.9%) |
| Dec 2000 | -$11.70 M(+247.0%) | -$120.70 K(-80.9%) | -$11.70 M(+1.0%) |
| Sept 2000 | - | -$630.60 K(-93.2%) | -$11.58 M(+5.8%) |
| June 2000 | - | -$9.32 M(+471.3%) | -$10.95 M(+571.3%) |
| Mar 2000 | - | -$1.63 M | -$1.63 M |
| Dec 1999 | -$3.37 M | - | - |
FAQ
- What is Infinity Pharmaceuticals annual net profit?
- What is the all time high annual net income for Infinity Pharmaceuticals?
- What is Infinity Pharmaceuticals annual net income year-on-year change?
- What is Infinity Pharmaceuticals quarterly net profit?
- What is the all time high quarterly net income for Infinity Pharmaceuticals?
- What is Infinity Pharmaceuticals quarterly net income year-on-year change?
- What is Infinity Pharmaceuticals TTM net profit?
- What is the all time high TTM net income for Infinity Pharmaceuticals?
- What is Infinity Pharmaceuticals TTM net income year-on-year change?
What is Infinity Pharmaceuticals annual net profit?
The current annual net income of INFI is -$44.37 M
What is the all time high annual net income for Infinity Pharmaceuticals?
Infinity Pharmaceuticals all-time high annual net profit is $23.65 M
What is Infinity Pharmaceuticals annual net income year-on-year change?
Over the past year, INFI annual net profit has changed by +$893.00 K (+1.97%)
What is Infinity Pharmaceuticals quarterly net profit?
The current quarterly net income of INFI is -$9.96 M
What is the all time high quarterly net income for Infinity Pharmaceuticals?
Infinity Pharmaceuticals all-time high quarterly net profit is $103.22 M
What is Infinity Pharmaceuticals quarterly net income year-on-year change?
Over the past year, INFI quarterly net profit has changed by +$2.03 M (+16.94%)
What is Infinity Pharmaceuticals TTM net profit?
The current TTM net income of INFI is -$40.95 M
What is the all time high TTM net income for Infinity Pharmaceuticals?
Infinity Pharmaceuticals all-time high TTM net profit is $23.65 M
What is Infinity Pharmaceuticals TTM net income year-on-year change?
Over the past year, INFI TTM net profit has changed by +$5.84 M (+12.48%)